RenovoRx, Inc. Board of Directors

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.

Mr. Shaun R. Bagai

Mr. Shaun R. Bagai

CEO, Secretary & Director

Ms. Leesa Gentry

Ms. Leesa Gentry

Chief Clinical Officer

Mr. Ronald B. Kocak CPA, CGMA

Mr. Ronald B. Kocak CPA, CGMA

VP, Controller & Principal Accounting Officer

Mr. Ryan Witt

Mr. Ryan Witt

Senior VP and Head of Corporate Strategy & Partnerships

Dr. Ramtin Agah M.D.

Dr. Ramtin Agah M.D.

Founder, Chairman of Board & Chief Medical Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.